Abstract
A prospective nonrandomized multicenter registry of 160 patients with severe carotid stenosis and high-risk features for carotid endarterectomy was conducted during the 3-month period from March to May 2005. Carotid artery stenting (CAS) was performed with the SpideRX™ Embolic Protection System (ev3, Inc., Plymouth, MN, USA) as part of an investigational device exemption from the Food and Drug Administration. The primary end-point of major adverse cardiac and cerebrovascular events at 30 days after CAS was observed in nine patients (5.6%), including death in four patients (2.5%), nonfatal stroke in five patients (3.1%), and nonfatal myocardial infarction in one patient (0.6%). A secondary end-point of technical success (defined as successful deployment of all devices, filter retrieval, and final diameter stenosis <50%) was achieved in 156 of 160 patients (97.5%). The only independent predictor of death or stroke at 30 days was baseline stenosis severity (P < 0.05). CAS with distal embolic protection using the SpideRX™ Embolic Protection System is a reasonable alternative for revascularization of some high-risk patients with severe carotid stenosis.
References
Aug 15, 1991·The New England Journal of Medicine·UNKNOWN North American Symptomatic Carotid Endarterectomy Trial CollaboratorsM Eliasziw
May 10, 1995·JAMA : the Journal of the American Medical Association
Apr 11, 2001·Journal of Vascular Surgery·K OurielJ S Yadav
May 12, 2004·Lancet·A HallidayUNKNOWN MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group
Sep 3, 2004·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Robert D SafianFrank J Criado
Oct 8, 2004·The New England Journal of Medicine·Jay S YadavUNKNOWN Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators
Dec 29, 2004·Journal of Vascular Surgery·Robert W HobsonUNKNOWN CREST Investigators
Jun 20, 2006·Journal of the American College of Cardiology·Robert D SafianUNKNOWN CREATE Pivotal Trial Investigators
Oct 10, 2006·Lancet·P A RinglebW Hacke
Oct 20, 2006·The New England Journal of Medicine·Jean-Louis MasUNKNOWN EVA-3S Investigators
Sep 26, 2007·Annals of Surgery·Ronald FairmanUNKNOWN CAPTURE Trial Collaborators
Nov 30, 2007·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·William A GrayUNKNOWN CAPTURE Trial Collaborators
Jan 29, 2008·Journal of the American College of Cardiology·Sriram S IyerUNKNOWN BEACH Investigators
Apr 12, 2008·The New England Journal of Medicine·Hitinder S GurmUNKNOWN SAPPHIRE Investigators
Apr 17, 2008·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·L Nelson HopkinsDonald S Baim
Citations
Nov 26, 2010·Current Cardiology Reports·Vincent V Truong, Alex Abou-Chebl
Oct 28, 2015·Journal of Vascular Surgery·Christopher J KwolekRichard P Cambria
Oct 22, 2013·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Punnaiah C MarellaRichard R Heuser
Jul 13, 2013·Journal of Interventional Cardiology·Mohammed Salim Al-DamlujiCarlos Mena
May 31, 2012·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Dimitrios NikasBernhard Reimers
Aug 16, 2014·Journal of the American College of Cardiology·Christopher J White
Jun 19, 2016·Postgraduate Medical Journal·Michael G NannaCarlos Mena